Francois Nader

Track

Insider profile

Currently holds a position at Moderna Inc

Performance

Overall performance
2.0
Performance over holding periods
2.0
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Non-Executive Independent Director Moderna Inc Dec. 10, 2019 -
Francois Nader's trades of Tourmaline Bio Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
34.73
Quantity 98,573 +0.2%
Value US$2,281,568
Transaction date
Purchase
Price
380.22
Quantity 63,896 -20.8%
Value US$4,532,529
Transaction date
Purchase
Price
285.84
Quantity 15,851 -20.9%
Value US$4,453,069
US Moderna Inc (MRNA)
Transaction date
Sale
Price
136.10
Quantity 3,196 -13.4%
Value US$434,976
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-07-25 2022-07-21
B Purchase
98,573 +0.2%
34.73
US$2,281,568 		98,573 +0.2% 34.73 US$2,281,568
2022-07-25 2022-07-20
B Purchase
63,896 -20.8%
380.22
US$4,532,529 		63,896 -20.8% 380.22 US$4,532,529
2022-07-25 2022-07-19
B Purchase
15,851 -20.9%
285.84
US$4,453,069 		15,851 -20.9% 285.84 US$4,453,069
2022-05-12 2022-05-10
US Moderna Inc (MRNA)
S Sale
3,196 -13.4%
136.10
US$434,976 		3,196 -13.4% 136.10 US$434,976